Standard

Проблема суицида при депрессии в современном мире. / Петрова, Наталия Николаевна.

In: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, Vol. 122, No. 6 Vyp 2, 2022, p. 43-48.

Research output: Contribution to journalArticlepeer-review

Harvard

Петрова, НН 2022, 'Проблема суицида при депрессии в современном мире', ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, vol. 122, no. 6 Vyp 2, pp. 43-48. https://doi.org/10.17116/jnevro202212206243

APA

Петрова, Н. Н. (2022). Проблема суицида при депрессии в современном мире. ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, 122(6 Vyp 2), 43-48. https://doi.org/10.17116/jnevro202212206243

Vancouver

Петрова НН. Проблема суицида при депрессии в современном мире. ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА. 2022;122(6 Vyp 2):43-48. https://doi.org/10.17116/jnevro202212206243

Author

Петрова, Наталия Николаевна. / Проблема суицида при депрессии в современном мире. In: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА. 2022 ; Vol. 122, No. 6 Vyp 2. pp. 43-48.

BibTeX

@article{a1cbc8203ad54df8b5122837f03e28a2,
title = "Проблема суицида при депрессии в современном мире",
abstract = "OBJECIVE: To analyze the literature data on the relationship between antidepressant therapy and suicide risk and the ways to prevent suicidal behavior in patients on antidepressant therapy. MATERIAL AND METHODS: A non-systematic review of publications was conducted using keywords in the following databases: ELibrary.ru, PubMed, Cochrane Database of Systematic Reviews. Inclusion criteria were meta-analyses, Cochrane reviews, epidemiological and original studies. RESULTS: Data from original studies are inconsistent, but more evidence-based epidemiologic studies support the preventive role of antidepressant therapy with regard to suicide. An increased risk of suicide with antidepressant therapy is seen in younger patients, especially in the first 2 weeks of treatment, in the absence of a therapeutic response. The initial dosage of antidepressants, possibly the type of antidepressant, is of some importance. The group at risk of committing suicide is those who have received psychotropic therapy in the previous year. CONCLUSION: There is no generally accepted model of prevention, but it is recommended that patients be observed during the first 4 weeks of treatment for depression, as well as during the period of antidepressant dose modification.",
keywords = "antidepressants, depression, suicide risk, antidepressants, depression, suicide risk",
author = "Петрова, {Наталия Николаевна}",
year = "2022",
doi = "10.17116/jnevro202212206243",
language = "русский",
volume = "122",
pages = "43--48",
journal = "ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА",
issn = "1997-7298",
publisher = "Медицина",
number = "6 Vyp 2",

}

RIS

TY - JOUR

T1 - Проблема суицида при депрессии в современном мире

AU - Петрова, Наталия Николаевна

PY - 2022

Y1 - 2022

N2 - OBJECIVE: To analyze the literature data on the relationship between antidepressant therapy and suicide risk and the ways to prevent suicidal behavior in patients on antidepressant therapy. MATERIAL AND METHODS: A non-systematic review of publications was conducted using keywords in the following databases: ELibrary.ru, PubMed, Cochrane Database of Systematic Reviews. Inclusion criteria were meta-analyses, Cochrane reviews, epidemiological and original studies. RESULTS: Data from original studies are inconsistent, but more evidence-based epidemiologic studies support the preventive role of antidepressant therapy with regard to suicide. An increased risk of suicide with antidepressant therapy is seen in younger patients, especially in the first 2 weeks of treatment, in the absence of a therapeutic response. The initial dosage of antidepressants, possibly the type of antidepressant, is of some importance. The group at risk of committing suicide is those who have received psychotropic therapy in the previous year. CONCLUSION: There is no generally accepted model of prevention, but it is recommended that patients be observed during the first 4 weeks of treatment for depression, as well as during the period of antidepressant dose modification.

AB - OBJECIVE: To analyze the literature data on the relationship between antidepressant therapy and suicide risk and the ways to prevent suicidal behavior in patients on antidepressant therapy. MATERIAL AND METHODS: A non-systematic review of publications was conducted using keywords in the following databases: ELibrary.ru, PubMed, Cochrane Database of Systematic Reviews. Inclusion criteria were meta-analyses, Cochrane reviews, epidemiological and original studies. RESULTS: Data from original studies are inconsistent, but more evidence-based epidemiologic studies support the preventive role of antidepressant therapy with regard to suicide. An increased risk of suicide with antidepressant therapy is seen in younger patients, especially in the first 2 weeks of treatment, in the absence of a therapeutic response. The initial dosage of antidepressants, possibly the type of antidepressant, is of some importance. The group at risk of committing suicide is those who have received psychotropic therapy in the previous year. CONCLUSION: There is no generally accepted model of prevention, but it is recommended that patients be observed during the first 4 weeks of treatment for depression, as well as during the period of antidepressant dose modification.

KW - antidepressants

KW - depression

KW - suicide risk

KW - antidepressants

KW - depression

KW - suicide risk

UR - http://www.scopus.com/inward/record.url?scp=85134361071&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/67aa2fe2-4bad-3df6-a6a5-1ae64bb5fd9c/

U2 - 10.17116/jnevro202212206243

DO - 10.17116/jnevro202212206243

M3 - статья

VL - 122

SP - 43

EP - 48

JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

SN - 1997-7298

IS - 6 Vyp 2

ER -

ID: 97145165